Compare UiPath Inc (PATH) vs Xylem, Inc. (XYL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
UiPath Inc vs Xylem, Inc. — how do they compare? UiPath Inc trades at $13.3 (market cap $6.81B), while Xylem, Inc. trades at $102.31 (market cap $23.77B). The key difference: Xylem, Inc. is far larger — about 3.5× UiPath Inc's market cap, and Xylem, Inc. pays a 1.69% dividend while UiPath Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold UiPath Inc for 139 Days and Xylem, Inc. for 50 Days on average.
| PATH | XYL | |
|---|---|---|
Market Cap | $6.81B | $23.77B |
Volume | 22,766,109 | 2,477,250 |
Sector | Technology | Industrials |
52-Week High | $19.29 | $152.95 |
52-Week Low | $9.38 | $100.92 |
Typical Hold Time | 139 Days | 50 Days |
Enterprise Value | $5.61B | $25.55B |
Dividend Yield | — | 1.69% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
UiPath (PATH) trades at $13.07, down 0.23% on the day, amid a bearish technical signal and mixed earnings history. The company shows improving fundamentals with revenue growing from $1.43B in 2025 to a projected $1.7B in 2026, while net income is expected to turn positive. Recent news highlights AI partnerships and product innovations, but the stock faces headwinds from cautious analyst sentiment and technical resistance.
The outlook for PATH is cautiously optimistic, with strong revenue growth and a path to profitability offering upside potential, but risks include execution challenges and competitive pressures. The consensus price target of $15.13 suggests moderate upside from current levels, though investor sentiment remains divided.
Xylem (XYL) trades at $101.99, down 2.48% today, amid bearish technical signals but strong fundamentals. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results expected October 27. Revenue grew from $5.5B in 2022 to $9.04B in 2025, while net income margin expanded to 10.59%. Recent acquisitions of Cornell Pump and Roper Pump strengthen industrial presence.
Outlook remains positive with 47.5% analyst buy ratings and $149.13 consensus price target, representing 46% upside. Key risks include China weakness and higher debt from recent note offerings. The stock offers value with P/E of 24.24 and consistent dividend payments, though technical indicators suggest near-term pressure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About UiPath Inc
UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.
Read more on PATH →About Xylem, Inc.
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.
Read more on XYL →
